Journal List > Ann Clin Microbiol > v.20(4) > 1078566

Lee, Shin, and Kim: Rapid Detection of Group B Streptococcus Using ChromID STRB and PCR in the Pregnant Women

Abstract

Background

Group B Streptococcus (GBS) can be transmitted to neonates during delivery through the birth canal. As awareness of neonatal GBS infections is increasing, more rapid and efficient screening tests are required. The aim of this study was to evaluate the performance of ChromID STRB (bioMérieux, France) and PCR compared with the standard culture method.

Methods

Recto-vaginal swabs were collected from 775 pregnant women from April 2016 to March 2017. Cotton swab cultures were grown in LIM broth overnight and then subcultured onto blood agar plates and ChromID STRB. PCR was carried out to detect atr genes specific for GBS.

Results

The carrier rate of GBS was 5.9% (46/775). The sensitivity, specificity, positive predictive value, and negative predictive value were 83.8%, 99.3%, 86.1%, and 99.2%, respectively, for ChromID STRB and 89.2%, 99.6%, 91.7%, and 99.5%, respectively for PCR. Both ChromID STRB and PCR detected 6 more cases compared to the standard culture.

Conclusion

Chromogenic agar, ChromID STRB, and PCR using the atr gene showed excellent performance to screen for GBS. To administer prophylactic antibiotics efficiently, either selective chromogenic agar or PCR could be used in addition to the standard culture.

References

1. Bergeron MG, Ke D, Ménard C, Picard FJ, Gagnon M, Bernier M, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med. 2000; 343:175–9.
crossref
2. Centers for Disease Control and Prevention (CDC). Early-onset and late-onset neonatal group B streptococcal disease–United States, 1996–2004. MMWR Morb Mortal Wkly Rep. 2005; 54:1205–8.
3. Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics. 2011; 127:817–26.
crossref
4. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010; 59:1–36.
5. Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis. 2004; 39:1129–35.
crossref
6. Park JS, Cho DH, Yang JH, Kim MY, Shin SM, Kim EC, et al. Usefulness of a rapid realtime PCR assay in prenatal screening for group B streptococcus colonization. Ann Lab Med. 2013; 33:39–44.
crossref
7. Verhoeven PO, Noyel P, Bonneau J, Carricajo A, Fonsale N, Ros A, et al. Evaluation of the new brilliance GBS chromogenic medium for screening of Streptococcus agalactiae vaginal colonization in pregnant women. J Clin Microbiol. 2014; 52:991–3.
crossref
8. Yao K, Poulsen K, Maione D, Rinaudo CD, Baldassarri L, Telford JL, et al. Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. J Clin Microbiol. 2013; 51:503–7.
crossref
9. Poyart C, Tazi A, Réglier-Poupet H, Billoët A, Tavares N, Raymond J, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol. 2007; 45:1985–8.
crossref
10. Glaser P, Rusniok C, Buchrieser C, Chevalier F, Frangeul L, Msadek T, et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol. 2002; 45:1499–513.
crossref
11. de-Paris F, Machado AB, Gheno TC, Ascoli BM, Oliveira KR, Barth AL. Group B Streptococcus detection: comparison of PCR assay and culture as a screening method for pregnant women. Braz J Infect Dis. 2011; 15:323–7.
crossref
12. Rosa-Fraile M and Spellerberg B. Reliable detection of group B streptococcus in the clinical laboratory. J Clin Microbiol. 2017; 55:2590–8.
crossref
13. Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012; 55:91–102.
crossref
14. De Luca C, Buono N, Santillo V, Licameli A, Straface G, Scambia G, et al. Screening and management of maternal colonization with Streptococcus agalactiae: an Italian cohort study. J Matern Fetal Neonatal Med. 2016; 29:911–5.
15. Bianco A, Larosa E, Pileggi C, Pavia M. Collaborative Working Group. Appropriateness of intrapartum antibiotic prophylaxis to prevent neonatal group B Streptococcus disease. PLoS One. 2016; 11:e0166179.
crossref
16. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol. 2000; 96:498–503.
crossref
17. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996; 88:811–5.
crossref
18. Uh Y, Jang IH, Yoon KJ, Lee CH, Kwon JY, Kim MC. Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital. Eur J Clin Microbiol Infect Dis. 1997; 16:753–6.
crossref
19. Kim TH, Park SE, Kim KH. A study of group B streptococcal infection in pregnant women, by Lim broth media. Korean J Pediatr. 2004; 47:1072–5.
20. Choi SJ, Park SD, Jang IH, Uh Y, Lee A. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. Ann Lab Med. 2012; 32:194–200.
crossref
21. Kim EJ, Oh KY, Kim MY, Seo YS, Shin JH, Song YR, et al. Risk factors for group B streptococcus colonization among pregnant women in Korea. Epidemiol Health. 2011; 33:e2011010.
crossref
22. Rosa-Fraile M, Camacho-Muñoz E, Rodríguez-Granger J, Liébana-Martos C. Specimen storage in transport medium and detection of group B streptococci by culture. J Clin Microbiol. 2005; 43:928–30.
crossref
23. Baker CJ, Clark DJ, Barrett FF. Selective broth medium for isolation of group B streptococci. Appl Microbiol. 1973; 26:884–5.
crossref
24. Ghaddar N, Alfouzan W, Anastasiadis E, Al Jiser T, Itani SE, Dernaika R, et al. Evaluation of chromogenic medium and direct latex agglutination test for detection of group B streptococcus in vaginal specimens from pregnant women in Lebanon and Kuwait. J Med Microbiol. 2014; 63:1395–9.
crossref
25. Alfa MJ, Sepehri S, De Gagne P, Helawa M, Sandhu G, Harding GK. Real-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus. J Clin Microbiol. 2010; 48:3095–9.
26. Donati L, Di Vico A, Nucci M, Quagliozzi L, Spagnuolo T, Labianca A, et al. Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet. 2010; 281:589–600.
crossref
27. Poisson DM, Evrard ML, Freneaux C, Vivès MI, Mesnard L. Evaluation of CHROMagar TM StrepB agar, an aerobic chromogenic medium for prepartum vaginal/rectal group B Streptococcus screening. J Microbiol Methods. 2011; 84:490–1.

Table 1.
Primer sequences that were used in PCR for GBS detection
Amplified gene Primer sequence (5′-3′) Size (bp)
atr Forward CAA CGA TTC TCT CAG CTT TGT TAA 780
Reverse TAA GAA ATC TCT TGT GCG GAT TTC  
Table 2.
Combination of the results of each screening test of GBS
Standard culture PCR ChromID STRB N
Positive Positive Positive 27
Positive Positive Negative 6
Positive Negative Positive 4
Negative Positive Positive 3
Positive Negative Negative 0
Negative Positive Negative 3
Negative Negative Positive 3
Negative Negative Negative 729
  Total   775
Table 3.
Performance of ChromID STRB and PCR test compared to standard culture (95% confidence interval)
Parameters ChromID STRB PCR
Sensitivity (%) 83.9 (68.0–93.8) 89.2 (74.6–97.0)
Specificity (%) 99.3 (98.4–99.8) 99.6 (98.8–99.9)
Positive predictive value (%) 86.1 (71.9–93.8) 91.7 (78.0–97.2)
Negative predictive value (%) 99.2 (98.3–99.6) 99.5 (98.7–99.8)
P value* 1.00 0.75
Turn-around time (hours) 18–48 6–8

*Compared with standard culture method;

TAT does not include primary culture in the LIM broth.

TOOLS
Similar articles